Continuous glucose monitoring (CGM) has been greatly implicated in clinical practice for various parts of diabetic management. The CGM could be set as professional or blinded and unblinded in different clinical application. The more recent advance in CGM is the development of glucotypes, which are the fundamental of personalized medicine and artificial management in big data derived from CGM. This review will focus on the clinical assessment and value of CGM from the basics to scientific future.